Could This Non-Profit Drugmaker Solve U.S. Insulin Crisis?
SOMETHING’S GOTTA GIVEIt’s planning to produce the diabetes drug at no more than $30 for a month’s supply—a fraction of some private pharma companies.
It’s planning to produce the diabetes drug at no more than $30 for a month’s supply—a fraction of some private pharma companies.